With New Focus, Firm Announces Practice Expansion to Life Sciences and Public Health Preparedness
May 15, 2008
May 15, 2008 - (Washington, DC) - McKenna Long & Aldridge LLP (MLA) presented its expanded Life Sciences and Public Health Preparedness practice by introducing the team’s industrial biotechnology capabilities at the Biotechnology Industry Organization’s (BIO) World Congress On Biotechnology & Bioprocessing Conference, which took place in Chicago April 27 - 30, 2008.
MLA provides a multi-faceted industrial biotechnology resource for businesses interested in the application of enabling biotechnology for newly emerging industries such as biofuels and bioremediation. The Firm helps clients develop and secure funding for a variety of projects ranging from solutions for rising energy concerns to harnessing biotechnology innovations for non-medical applications.
“The industrial biotechnology market and opportunities are driven by both environmental and climate issues, as well as national security concerns,” said John Clerici, Chair of the Firm’s Life Sciences and Public Health Preparedness practice. “The Firm’s 70-year pedigree in the national security arena as the original and largest government contracts firm coupled with our market-leading public health and biodefense practice made the evolution in industrial biotechnology and life sciences an organic process.”
The Industrial Biotechnology team offers a range of business planning and government relations tools to successfully create domestic and international markets for transgenic plants and biomass conversion for biofuels, and the application of biotechnology processes for other industrial processes such as decontamination and organic matter clean-up. The team also works to create profitable partnerships between biotechnology industry members and leaders in the federal government, the European Union and various defense, energy and health ministries throughout Europe.